Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference20 articles.
1. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells;Chen;Blood,1997
2. Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage;Shen;Leukemia,2001
3. Arsenic trioxide, a therapeutic agent for APL;Zhang;Oncogene,2001
4. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia;Estey;Blood,2006
5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients;Shen;Blood,1997
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications;Cell Death Discovery;2023-07-27
2. Mechanistic update of Trisenox in blood cancer;Current Research in Pharmacology and Drug Discovery;2023
3. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells;Frontiers in Oncology;2021-09-28
4. Is the EGFR pathway relevant for the pathogenesis but not for treatment of acute myeloid leukemia?;Journal of Cancer Metastasis and Treatment;2021
5. Toxicity of arsenicals in diseases: friend or foe?;Toxicological Risk Assessment and Multi-System Health Impacts from Exposure;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3